Loading...
Regulatory Delays And Setbacks Will Restrict Adoption Yet Allow Recovery
AnalystLowTarget's Fair Value
US$14.50
7.0% undervalued intrinsic discount04 Sep
US$13.49
1Y
-16.0%7D
-7.0%1Y
-16.0%7D
-7.0%You can edit this narrative until Aug 6 10:18 PM. Then, changes will post as Updates.